 |
|
Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Yangjin Jegal, Jong Sun Park, Song Yee Kim, Hongseok Yoo, Sung Hwan Jeong, Jin Woo Song, Jae Ha Lee, Hong Lyeol Lee, Sun Mi Choi, Young Whan Kim, Yong Hyun Kim, Hye Sook Choi, Jongmin Lee, Soo-Taek Uh, Tae-Hyung Kim, Sang-Heon Kim, Won-Yeon Lee, Yee Hyung Kim, Hyun-kyung Lee, Eun Joo Lee, Eun Young Heo, Sei Hoon Yang, Hyung Koo Kang, Man Pyo Chung,
Tuberc Respir Dis. 2022;85(2):185-194. Published online 2021 Dec 13 DOI: https://doi.org/10.4046/trd.2021.0123
|
|
Citations to this article as recorded by
 Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan
Kotaro Iwasaki, Hiroki Wakabayashi, Atsuhito Saiki, Hajime Ueshiba, Yu Murakami, Yasuo Matsuzawa
Drugs - Real World Outcomes.2024; 11(1): 43. CrossRef Mechanical ventilation in patients with idiopathic pulmonary fibrosis in Korea: a nationwide cohort study
Jae Kyeom Sim, Seok Joo Moon, Juwhan Choi, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim
The Korean Journal of Internal Medicine.2024; 39(2): 295. CrossRef The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
Sheiphali A. Gandhi, Bohyung Min, Jane C. Fazio, Kerri A. Johannson, Craig Steinmaus, Carl J. Reynolds, Kristin J. Cummings
Annals of the American Thoracic Society.2024; 21(3): 486. CrossRef Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
Hyeonsu Lee, So Yeon Kim, Young Sik Park, Sun Mi Choi, Jong Hyuk Lee, Jimyung Park
Scientific Reports.2024;[Epub] CrossRef Clustering analysis of HRCT parameters measured using a texture-based automated system: relationship with clinical outcomes of IPF
Jong-Uk Lee, Jong-Sook Park, Eunjeong Seo, Jin Seol Kim, Hae Ung Lee, Yongjin Chang, Jai Seong Park, Choon-Sik Park
BMC Pulmonary Medicine.2024;[Epub] CrossRef Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias
Hironao Hozumi, Koichi Miyashita, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Respiratory Research.2024;[Epub] CrossRef Effect of Antifibrotic Use on Mortality in Patients with Idiopathic Pulmonary Fibrosis
Huiping Xu, Siu L. Hui, Joyce S. Lee, Zuoyi Zhang, Ryan D. Boente
Annals of the American Thoracic Society.2024; 21(10): 1407. CrossRef Prevalence, Clinical Features, and Outcomes of Young Patients with Idiopathic Pulmonary Fibrosis
Jeewon Lee, Kyung Joo Kim, Jung Hyun Nam, Joon Young Choi, Chin Kook Rhee, Yong Suk Jo
Respiration.2024; : 1. CrossRef Rethinking treatment strategies for idiopathic pulmonary fibrosis: Reevaluation of anti-inflammatory and immunosuppressive therapies
Masashi Bando
Respiratory Investigation.2023; 61(1): 58. CrossRef Antifibrotics and Reduced Mortality in Idiopathic Pulmonary Fibrosis: Immortal Time Bias
Samy Suissa, Karine Suissa
American Journal of Respiratory and Critical Care Medicine.2023; 207(1): 105. CrossRef Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
Jang Ho Lee, Hyung Jun Park, Seonok Kim, Ye-Jee Kim, Ho Cheol Kim
BMC Pulmonary Medicine.2023;[Epub] CrossRef Russian Registry of Idiopathic Pulmonary Fibrosis: Clinical Features, Treatment Management, and Outcomes
Svetlana Chikina, Alexander Cherniak, Zamira Merzhoeva, Igor Tyurin, Natalia Trushenko, Anna Proshkina, Kirill Ataman, Sergey Avdeev
Life.2023; 13(2): 435. CrossRef Pharmacological Activities of Mogrol: Potential Phytochemical against Different Diseases
Varun Jaiswal, Hae-Jeung Lee
Life.2023; 13(2): 555. CrossRef The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study
Qiang Zheng, Petr Otahal, Ingrid A. Cox, Barbara de Graaff, Julie A. Campbell, Hasnat Ahmad, E. Haydn Walters, Andrew J. Palmer
Frontiers in Medicine.2023;[Epub] CrossRef Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis
Francesco Bonella, Paolo Spagnolo, Chris Ryerson
Drugs.2023; 83(17): 1581. CrossRef Outcomes of Patients on the Lung Transplantation Waitlist in Korea: A Korean Network for Organ Sharing Data Analysis
Hye Ju Yeo, Dong Kyu Oh, Woo Sik Yu, Sun Mi Choi, Kyeongman Jeon, Mihyang Ha, Jin Gu Lee, Woo Hyun Cho, Young Tae Kim
Journal of Korean Medical Science.2022;[Epub] CrossRef
|